CJC-1295 without DAC (Drug Affinity Complex) is a modified fragment of growth hormone-releasing hormone (GHRH), designed for pulsatile GH stimulation with a shorter half-life compared to its DAC-bound counterpart. This version is commonly researched in protocols involving multiple daily dosing or in combination with other secretagogues to mimic natural growth hormone release patterns.
Studies have explored its role in supporting lean body mass, recovery, and age-related decline in endogenous GH production.
This compound is offered as a lyophilized powder in sterile, unlabeled glass vials to ensure purity and versatility in research settings. Our 10-vial research kits are produced under stringent quality control protocols and are independently batch-tested for identity and purity.
Each vial is intended for in vitro use only. Not for human consumption. Not for therapeutic or diagnostic purposes.
